Pulmonary injury after intestinal ischemia and reperfusion injury: effects of treatment with lexipafant, a PAF antagonist

Схожие документы

• Antibodies to ICAM-1 and PECAM-1 ameliorate pulmonary injury after intestinal ischemia-reperfusion in the rat
  по: Börjesson, A, et al.
  Опубликовано: (1998)
• Intestinal ischemia and reperfusion: beneficial effects of a platelet activating factor antagonist
  по: Andersson, R, et al.
  Опубликовано: (1999)
• Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment
  по: Souza, Danielle G, et al.
  Опубликовано: (2003)
• Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury.
  по: Caty, M G, et al.
  Опубликовано: (1990)
• Microbiome and intestinal ischemia/reperfusion injury
  по: Nadatani, Yuji, et al.
  Опубликовано: (2018)